药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Haloprogin
Halofantrine
The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Halofantrine.
Haloprogin
Sparfloxacin
The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Sparfloxacin.
Haloprogin
Domperidone
The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Domperidone.
Haloprogin
Escitalopram
The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Escitalopram.
Haloprogin
Arsenic trioxide
The risk or severity of QTc prolongation can be increased when Ofloxacin is combined with Arsenic trioxide.
Haloprogin
Iron isomaltoside 1000
Iron isomaltoside 1000 can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Haloprogin
Ferric maltol
Ferric maltol can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Haloprogin
Sodium feredetate
Sodium feredetate can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Haloprogin
Ferrous fumarate
Ferrous fumarate can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Haloprogin
Ferrous succinate
Ferrous succinate can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Haloprogin
Ferrous gluconate
Ferrous gluconate can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Haloprogin
Ferrous chloride
Ferrous chloride can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Haloprogin
Ferric hydroxide
Ferric hydroxide can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Haloprogin
Ferrous sulfate anhydrous
Ferrous sulfate anhydrous can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Haloprogin
Perflubutane
Perflubutane can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Haloprogin
Ferric oxide
Ferric oxide can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Haloprogin
Gleptoferron
Gleptoferron can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Haloprogin
Ferrous bisglycinate
Ferrous bisglycinate can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Haloprogin
Ferumoxides
Ferumoxides can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.
Haloprogin
Ferumoxsil
Ferumoxsil can cause a decrease in the absorption of Ofloxacin resulting in a reduced serum concentration and potentially a decrease in efficacy.